Why the study?
Does losartan reduce myocardial fibrosis and left ventricular chamber stiffness in patients with essential hypertension?
Does losartan reduce myocardial fibrosis and left ventricular chamber stiffness in patients with essential hypertension?
Losartan may improve left ventricular chamber stiffness by regressing myocardial fibrosis in patients with essential hypertension.
No takes yet. Share an insight, caveat, or question.
Losartan may improve LV stiffness via fibrosis regression in hypertension; leaves open confirmation in randomized outcome trials.
Dı́ez et al. (2002) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: